A significantly high percentage of CD14+CD16+ cells was detected in all the MM patients regardless of the question of bone disease, both at diagnosis and after treatment as compared to the controls, p < 0.001 (Figure 3). This evidence concerns the gene CD14 and Miyoshi myopathy.